Live
CellA skin-hypothalamus axis couples heat stress and metabolic dysfunctionCellThe evolution of high-order genome architecture revealed from 1,000 speciesCellSomatic cancer variants enriched in Alzheimer’s disease microglia-like cells drive inflammatory and proliferative statesCellPyruvate is a natural suppressor of interferon signaling by inducing STAT1 protein pyruvylationCellMechanism-guided identification of antidepressant G protein-coupled receptor drug targetsBDArea Softball: PRB gets 2 wins - Brainerd DispatchFierceBiotechWCG acquires The Contract Network in bid to streamline clinical trial executionRecursionRecursion Pharmaceuticals director Gibson sells $144,400 in stock By Investing.com - Investing.com CanadaRecursionRecursion Pharmaceuticals (NASDAQ: RXRX) director sells 40K shares under plan - Stock TitanRecursion[SCHEDULE 13G/A] RECURSION PHARMACEUTICALS, INC. Amended Passive Investment Disclosure - Stock Titan
Endpoints News Nov 26, 2025

Lundbeck backs out of bidding war for sleep disorder biotech Avadel

Lundbeck backs out of bidding war for sleep disorder biotech Avadel

Body unavailable. Use the original source.